about
sameAs
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesHIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future researchNHLBI perspectives on the growth of heart, lung, blood and sleep conditions in Africa: global and domestic insights, challenges and opportunitiesDynamic deformability of sickle red blood cells in microphysiological flow.2015 Clinical trials update in sickle cell anemiaA biophysical indicator of vaso-occlusive risk in sickle cell disease.In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technologyEvaluation of SWI in children with sickle cell disease.Hemoglobin and mean platelet volume predicts diffuse T1-MRI white matter volume decrease in sickle cell disease patients.Neglect is more common and severe at extreme hemoglobin levels in right hemispheric stroke.Major artery occlusion: a rare complication of sickle cell disease.[Genetics of ischemic stroke].Periodic limb movements and disrupted sleep in children with sickle cell disease.Mechanisms linking red blood cell disorders and cardiovascular diseasesSickle cell disease activates peripheral blood mononuclear cells to induce cathepsins k and v activity in endothelial cells.Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease miceO-Linked N-Acetylglucosamine (O-GlcNAc) Transferase and O-GlcNAcase Interact with Mi2β Protein at the Aγ-Globin Promoter.Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.Sickle Cell Disease with Cyanotic Congenital Heart Disease: Long-Term Outcomes in 5 Children.Iron in sickle-cell disease: what have we learned over the years?Current concepts in the management of stroke in children with sickle cell disease.Cerebral infarction in children with sickle cell disease: a concise overview.Potential role for statins in sickle cell disease.Improving outcomes in children with sickle cell disease: treatment considerations and strategies.Changes in cerebral blood flow in children with sickle cell disease after splenectomy.Update on sickle cell disease.Plasma glial fibrillary acidic protein levels in a child with sickle cell disease and stroke.Anemia and stroke: Where do we stand?Quantitative Analysis of Extracranial Arterial Tortuosity in Patients with Sickle Cell Disease.Sickle cell anemia in Brazil: personal, medical and endodontic patterns.Missed Opportunities for Transcranial Doppler Screening Among Children With Sickle Cell Disease.Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.Duffy and kidd genotyping facilitates pretransfusion testing in patients undergoing long-term transfusion therapy.Watershed Infarct in Beta-Thalassemia Major Patient.Brain Perfusion Impairment in Neurologically Asymptomatic Adult Patients with Sickle-Cell Disease Shown by Voxel-Based Analysis of SPECT ImagesCalpain-1 regulates platelet function in a humanized mouse model of sickle cell disease.Red blood cells in thrombosis.Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease.Brain magnetic resonance angiography in splenectomized adults with β-thalassemia intermedia.
P2860
Q24289511-DCADE6E7-F403-42AC-A425-AF87AC1CE546Q26827746-6A3BC35F-0DAE-4753-A8E7-AC14424A965FQ26859899-5C9F9C5F-814F-4276-8CA3-7CC9BA728BE2Q27316518-9F922863-466E-468D-853E-2727C7D7F622Q28086979-2EAFC713-0F0F-4737-91C1-CEFDEFBCD6CFQ30539106-08273907-8CDA-477D-8B27-C67A623951CDQ33398661-156EE3F5-5CCA-4666-A63E-EB280F47BFD5Q33624920-720F1935-B984-478A-92AB-DDB0359ECAACQ33679897-1634B307-7D3B-43C5-A71F-CA8228E5E36EQ34137736-738BC67D-3AF9-4E4F-ACD4-116CECAFEE7DQ34549164-A661AA11-FDDD-4B45-AA92-E43037A8DDC8Q34555157-E22A50FA-3EDF-47C4-989D-3C7DED829448Q35059196-87740724-4949-4815-AE57-77625AB97260Q35091967-B628FF11-B54B-46B6-AF9D-F7A239699C2FQ35895659-F7A6760A-0E46-425A-9CF6-FA90B956C17AQ36106307-F6D2DF14-E513-40BE-AE52-51B7B372DF49Q36143261-3333A67B-977B-4BF1-B3F9-A868552CFCF6Q37117294-83B7164D-7B6A-4DC1-91BC-5127E60047E3Q37458594-D3A74B17-91EA-4A35-A383-475A1FE02AA2Q37527752-5400A89A-97EB-4ADC-B4CC-1933401E7E0DQ37820936-3031B2A1-44E3-4121-AB86-BA4E86723C09Q37831815-B9338B1C-A99C-49FB-89D9-3DB9BE36CA2DQ37941865-0D716EA4-0353-4810-9020-5321E0BCAB22Q38071047-3D8D9C35-EAC9-4C11-B3E8-B9737CC80290Q38209472-890EDDAD-9EE4-4194-A8CD-2A3E25956EE3Q38420178-443ED464-7035-4B80-A9F2-9E4BC55BB902Q38806417-BB9C65E1-BF34-4DDA-82F5-295A2B9586A6Q38844495-CF294A5B-E7AF-4348-9A21-2D303D88D67FQ38915112-5F16F6A0-603C-49E8-B07C-770C7982F57CQ39044394-E7FA346B-7CD7-4BFD-8F54-95F8AA477910Q39737459-2F74F4EA-BC66-4A3E-B184-9B5396F534C7Q40354230-4D299235-56AD-40C5-AE35-7E0217CFF5F9Q40787085-0B063680-6DF2-4142-8EC6-F70719DB2C84Q41820533-4EF2C890-F8DA-43F7-950E-E6CE8D41FA32Q41823774-7FFD240B-560B-41D1-8096-7721603163D3Q42451901-EBCC208A-3365-4679-B7D2-EE4A88E4E021Q47666229-457D9CD3-9A81-4067-9CE9-05BA805C2555Q48003288-78DE7B29-E906-44C9-A6E0-49D5BFC8C5C2Q48174073-6949EBB7-49D8-42B8-B9B7-AC473023E8EBQ48902450-13890E88-85C5-40FC-82D0-4A2613B716BD
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Sickle cell disease and stroke
@ast
Sickle cell disease and stroke
@en
Sickle cell disease and stroke
@nl
type
label
Sickle cell disease and stroke
@ast
Sickle cell disease and stroke
@en
Sickle cell disease and stroke
@nl
prefLabel
Sickle cell disease and stroke
@ast
Sickle cell disease and stroke
@en
Sickle cell disease and stroke
@nl
P2093
P1433
P1476
Sickle cell disease and stroke
@en
P2093
D. G. Nathan
David G Nathan
L. A. Verduzco
Luis A Verduzco
P304
P356
10.1182/BLOOD-2009-05-220921
P407
P577
2009-10-01T00:00:00Z
2009-12-10T00:00:00Z